Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

    NEXT STORY
    Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
    PREV STORY
    SIGA Announces Public Health Agency of Canada Contract Award to Purchase Up To Approximately $33 Million of Oral TPOXX®
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Matinas BioPharma Files Investigational New Drug Application With U.S. FDA for Lead Antibacterial Development Candidate MAT2501

    BEDMINSTER, N.J., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a ...

    author_avatar
    NASDAQ Market News

    Eric Dostie Memorial College Scholarship Now Accepting 2020 Applicants

    author_avatar
    NASDAQ Market News

    Atara Biotherapeutics Announces Planned Chief Executive Officer Transition

    SOUTH SAN FRANCISCO, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ...

    author_avatar
    NASDAQ Market News